Emre Yumlu 
U.S.-based medical technology firm BioSig Technologies (Nasdaq: BSGM) has officially shifted its business trajectory with a bold move into the tokenization of real-world assets (RWA). On May 28, 2025, the company finalized its merger with blockchain-focused Streamex Exchange Corporation, marking a significant pivot from medical innovation to blockchain-powered financial solutions.
From MedTech to Blockchain: A Strategic Evolution
Previously known for its work in the healthcare sector, BioSig is now refocusing entirely on digital asset infrastructure, aiming to bring transparency and efficiency to the global commodities markets. With the completed merger, Streamex becomes a wholly owned subsidiary of BioSig, and a new leadership team has taken the helm.
-
Henry McPhie, co-founder of Streamex, is now BioSig’s Chief Executive Officer.
-
Morgan Lekstrom, the other Streamex co-founder, has been appointed Chairman of the Board.
-
Former BioSig CEO Anthony Amato will remain on the board to support the transition phase.
$1.1 Billion Growth Capital Secured for Gold-Backed Tokenization
Shortly after the merger, BioSig revealed it had secured up to $1.1 billion in growth capital through a mix of equity and debt financing:
-
$100 million in senior secured convertible debentures
-
A $1 billion equity line of credit to be drawn over the next 36 months
These funds will be used to tokenize physical commodities, starting with gold. The first product in this line will be a gold-backed treasury management solution aimed at institutional investors seeking blockchain-based alternatives to traditional exposure to precious metals.
The product’s technical foundation is built on Solana blockchain infrastructure, designed by Streamex to offer fast, cost-efficient, and transparent operations.
Advisory Power and Capital Markets Support
To support its new strategic direction, BioSig has brought on seasoned advisors:
-
Frank Giustra, founder of Wheaton Precious Metals and GoldCorp, will consult on commodities strategy
-
Capital markets experts Mathew August and Mitch Williams will assist in financial structuring and expansion
On the financing side, Cantor Fitzgerald and Clear Street are acting as co-lead placement agents, helping to drive the capital raise forward.
A New Standard in Value: Gold-Backed Digital Assets
BioSig’s new CEO Henry McPhie sees this shift as more than just a corporate change — he views it as a transformative moment in global finance:
“By merging the timeless value of physical gold with the innovation of blockchain, we are building a company anchored in what we believe is the world’s most trusted store of value.”
Under this vision, BioSig plans to denominate a significant portion of its balance sheet in physical gold, moving away from fiat currency. These reserves will then be monetized through Streamex’s proprietary tokenization technology, introducing new revenue streams and blockchain-native products.
You can also freely share your thoughts and comments about the topic in the comment section. Additionally, don’t forget to follow us on our Telegram, YouTube, and Twitter channels for the latest news and updates.